๐—ง๐—ถ๐—บ๐—ฒ ๐—ณ๐—ผ๐—ฟ ๐˜๐—ต๐—ฒ ๐—š๐—ฒ๐—ฟ๐—บ๐—ฎ๐—ป ๐—ฆ๐—ฝ๐—ฟ๐—ถ๐—ป๐—ด ๐—–๐—ผ๐—ป๐—ณ๐—ฒ๐—ฟ๐—ฒ๐—ป๐—ฐ๐—ฒ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ ๐—ถ๐—ป ๐—™๐—ฟ๐—ฎ๐—ป๐—ธ๐—ณ๐˜‚๐—ฟ๐˜ -๐—Ÿ๐—ฒ๐—ผ ๐—œ๐—ป๐˜๐—ฒ๐—ฟ๐—ป๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—ฃ๐—ฟ๐—ฒ๐—ฐ๐—ถ๐˜€๐—ถ๐—ผ๐—ป ๐—›๐—ฒ๐—ฎ๐—น๐˜๐—ต ๐—”๐—š ๐—ถ๐˜€ ๐—ท๐—ผ๐—ถ๐—ป๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ฒ ๐—ฎ๐—ฐ๐˜๐—ถ๐—ผ๐—ป!

The Equity Forum ่ฏ้ข˜ๆ ‡็ญพ#GermanSpringConference in Frankfurt is one of Germanyโ€™s leading capital market events, bringing together listed companies, investors, analysts and financial media. The conference offers a platform for companies to present their latest business developments, financial results and strategic outlooks while fostering direct exchange with the financial community.
Following todayโ€™s announcement regarding the planned acquisition of nine additional assets, ่ฏ้ข˜ๆ ‡็ญพ#LeoInternationalPrecisionHealth (โ€œLIPHโ€, ticker: LEOW) will provide further insights during its presentation and press conference at the Spring Conference 2026 in Frankfurt.

๐——๐—ฎ๐˜๐—ฒ: ๐— ๐—ผ๐—ป๐—ฑ๐—ฎ๐˜†, ๐Ÿญ๐Ÿญ ๐— ๐—ฎ๐˜† ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ
๐—ง๐—ถ๐—บ๐—ฒ: ๐Ÿฑ:๐Ÿฑ๐Ÿฌ ๐—ฝ.๐—บ. ๐—–๐—˜๐—ฆ๐—ง
๐—ฅ๐—ผ๐—ผ๐—บ: ๐˜๐—ฏ๐—ฑ, ๐—ฆ๐—ฒ๐˜€๐˜€๐—ถ๐—ผ๐—ป ๐—œ๐—œ๐—œ
๐—ฃ๐—ฟ๐—ฒ๐˜€๐—ฒ๐—ป๐˜๐—ฒ๐—ฟ: ๐—Ÿ๐—ฒ๐—ผ ๐—ช๐—ฎ๐—ป๐—ด, ๐—–๐—ต๐—ฎ๐—ถ๐—ฟ๐—บ๐—ฎ๐—ป ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐—ฆ๐˜‚๐—ฝ๐—ฒ๐—ฟ๐˜ƒ๐—ถ๐˜€๐—ผ๐—ฟ๐˜† ๐—•๐—ผ๐—ฎ๐—ฟ๐—ฑ

During the event, Leo Wang will highlight LIPH AGโ€™s strategic growth plans and provide further insight into the planned transaction as well as discuss its strategic significance for building a high-quality, scalable portfolio of healthcare assets.
The first step in this strategy is the intended acquisition of all shares in the Japanese company Funnel Ad Inc. (Funnel Group) – which operates approximately 50 beauty clinics across Japan – announced today, providing LIPH with immediate access to a profitable healthcare services platform in a key Asian market.

The transaction is expected to generate significant strategic and operational synergies, serving as a core building block of ่ฏ้ข˜ๆ ‡็ญพ#LIPHโ€™s platform by combining scale, recurring revenue, and direct patient access. It will also enable the rollout of additional products and services, including diagnostics, nutraceuticals, and AI-driven applications, while supporting cross-portfolio synergies and accelerating ecosystem integration.

Please find more information about the planned acquisition: https://lnkd.in/gJnFEm2V

More information on LIPH AG: https://www.liphag.com/

๐—Ÿ๐—ฒ๐—ผ ๐—ช๐—ฎ๐—ป๐—ด, ๐—™๐—ผ๐˜‚๐—ป๐—ฑ๐—ฒ๐—ฟ ๐—ผ๐—ณ ๐—Ÿ๐—ฒ๐—ผ ๐—œ๐—ป๐˜๐—ฒ๐—ฟ๐—ป๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—š๐—ฟ๐—ผ๐˜‚๐—ฝ ๐—ฎ๐—ป๐—ฑ ๐—–๐—ต๐—ฎ๐—ถ๐—ฟ๐—บ๐—ฎ๐—ป ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐—ฆ๐˜‚๐—ฝ๐—ฒ๐—ฟ๐˜ƒ๐—ถ๐˜€๐—ผ๐—ฟ๐˜† ๐—•๐—ผ๐—ฎ๐—ฟ๐—ฑ ๐—ผ๐—ณ ๐—Ÿ๐—ฒ๐—ผ ๐—œ๐—ป๐˜๐—ฒ๐—ฟ๐—ป๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—ฃ๐—ฟ๐—ฒ๐—ฐ๐—ถ๐˜€๐—ถ๐—ผ๐—ป ๐—›๐—ฒ๐—ฎ๐—น๐˜๐—ต ๐—”๐—š ๐—ท๐—ผ๐—ถ๐—ป๐˜€ ๐—ฏ๐—ถ๐—ผ:๐—ฐ๐—ฎ๐—ฝ ๐—ฐ๐—ผ๐—ป๐—ณ๐—ฒ๐—ฟ๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ถ๐—ป ๐—•๐—ฒ๐—ฟ๐—น๐—ถ๐—ป